RAXTOZINAMERAN
UNII N36VHK46PR

Substance Identification & Data

This profile provides standardized clinical and technical data for Raxtozinameran, uniquely identified by the FDA Unique Ingredient Identifier (UNII) N36VHK46PR.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2887554-49-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
N36VHK46PR
CAS Registry Number
2887554-49-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
RAXTOZINAMERAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C203101
National Cancer Institute reference terminology for clinical and research data.
INN ID
13075
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
nucleicAcid
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Raxtozinameran. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

RAXTOZINAMERAN

Common Names & Synonyms

MESSENGER RNA (MRNA), 5'-CAPPED, ENCODING A FULL-LENGTH, CODON-OPTIMISED PRE-FUSION STABILISED CONFORMATION VARIANT (K982P AND V983P) OF THE SARS-COV-2 (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2) SPIKE (S) GLYCOPROTEIN (OMICRON SUB-LINEAGE XBB.1.5; BASED UPON GISAID:EPI_ISL_17157779), FLANKED BY 5' AND 3' UNTRANSLATED REGIONS AND A 3' POLYADENYLATION (POLYA) TAIL; CONTAINS N1-METHYLPSEUDOURIDINE INSTEAD OF URIDINE (ALL-U>M1.PSI.)
RAXTOZINAMERAN [INN]
RAXTOZINAMERAN [WHO-DD]
RBP-020.2 4 (XBB.1.5 VARIANT)
RNA (RECOMBINANT 5'-(1,2-((3'-O-METHYL)M7G-(5'->5')-PPP-AM))-CAPPED ALL URIDINE->N1-METHYLPSEUDOURIDINE-SUBSTITUTED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN SECRETORY SIGNAL PEPTIDE PLUS CODON-OPTIMIZED PRE-FUSION SPIKE GLYCOPROTEIN OMICRON XBB.1.5 VARIANT (982-PROLINE,983-PROLINE)-SPECIFYING PLUS 5'-AND 3'-UNTRANSLATED FLANKING REGION-CONTAINING POLY(A)-TAILED MESSENGERRBP020.2 4), INNER SALT

Technical Codes

BNT162B2 OMICRON (XBB.1.5)

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus